These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6832377)

  • 1. Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4.
    Chakravarti DN; Campbell RD; Gagnon J
    FEBS Lett; 1983 Apr; 154(2):387-90. PubMed ID: 6832377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemical structure of the C4d fragment of the human complement component C4.
    Chakravarti DN; Campbell RD; Porter RR
    Mol Immunol; 1987 Nov; 24(11):1187-97. PubMed ID: 3696167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary sequence differences between Chido and Rodgers variants of tryptic C4d of the human complement system.
    Hellman U; Eggertsen G; Lundwall A; Engström A; Sjöquist J
    FEBS Lett; 1984 May; 170(2):254-8. PubMed ID: 6723966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The primary structure of the fourth component of human complement (C4)-C-terminal peptides.
    Law SK; Gagnon J
    Biosci Rep; 1985; 5(10-11):913-21. PubMed ID: 3841648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid sequence around the thiol and reactive acyl groups of human complement component C4.
    Campbell RD; Gagnon J; Porter RR
    Biochem J; 1981 Nov; 199(2):359-70. PubMed ID: 6978711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of the C4d.2 serologic allotype of murine complement component C4 to the C4d.1 allotype by site-specific mutagenesis.
    Mathias P; Shreffler DC; Cooper NR; Ogata RT
    J Immunol; 1990 Jan; 144(2):607-9. PubMed ID: 2295802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human complement component C4. Structural studies on the fragments derived from C4b by cleavage with C3b inactivator.
    Press EM; Gagnon J
    Biochem J; 1981 Nov; 199(2):351-7. PubMed ID: 6978710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.
    Taillon-Miller PA; Shreffler DC
    J Immunol; 1988 Oct; 141(7):2382-7. PubMed ID: 2459207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid sequence of the Bb fragment from human complement Factor B. Alignment of the cyanogen bromide-cleavage peptides.
    Gagnon J; Christie DL
    Biochem J; 1983 Jan; 209(1):51-60. PubMed ID: 6342609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C4d DNA sequences of two infrequent human allotypes (C4A13 and C4B12) and the presence of signal sequences enhancing recombination.
    Martínez-Quiles N; Paz-Artal E; Moreno-Pelayo MA; Longás J; Ferre-López S; Rosal M; Arnaiz-Villena A
    J Immunol; 1998 Oct; 161(7):3438-43. PubMed ID: 9759862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of the human complement component C4.
    Campbell RD; Dunham I; Kendall E; Sargent CA
    Exp Clin Immunogenet; 1990; 7(1):69-84. PubMed ID: 1971760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNBr cleavage of the light chain of human complement factor I and alignment of the fragments.
    Yuan JM; Hsiung LM; Gagnon J
    Biochem J; 1986 Jan; 233(2):339-45. PubMed ID: 2937401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of antibodies against the fourth complement component (C4) and development of a direct electroimmunoassay for quantification of C4d.
    Folkersen J; Teisner B; Petersen NE; Sim RB; Jessen E
    J Clin Lab Immunol; 1985 Mar; 16(3):163-7. PubMed ID: 4032454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
    Senaldi G; Makinde VA; Vergani D; Isenberg DA
    Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary structure of bovine complement activation fragment C4a, the third anaphylatoxin. Purification and complete amino acid sequence.
    Smith MA; Gerrie LM; Dunbar B; Fothergill JE
    Biochem J; 1982 Nov; 207(2):253-60. PubMed ID: 6760852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence analysis of the COOH terminus of the alpha-chain of the fourth component of human complement. Identification of the site of its extracellular cleavage.
    Hortin G; Chan AC; Fok KF; Strauss AW; Atkinson JP
    J Biol Chem; 1986 Jul; 261(19):9065-9. PubMed ID: 3722187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic determinants of human C4, Rodgers and Chido.
    Giles CM
    Exp Clin Immunogenet; 1988; 5(2-3):99-114. PubMed ID: 2483343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serine proteinase chain of human complement component C1s. Cyanogen bromide cleavage and N-terminal sequences of the fragments.
    Carter PE; Dunbar B; Fothergill JE
    Biochem J; 1983 Dec; 215(3):565-71. PubMed ID: 6362661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the cyanogen bromide fragments of the beta chain of human haptoglobin.
    Kurosky A; Hay RE; Kim H; Touchstone B; Rasco MA; Bowman BH
    Biochemistry; 1976 Nov; 15(24):5326-36. PubMed ID: 999809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the activation pathways of the complement in psoriatic patients by use of complement fragment C4d and Bb measurements.
    Takematsu H; Tagami H
    Dermatologica; 1989; 179 Suppl 1():16-9. PubMed ID: 2789155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.